Literature DB >> 26494294

Idiopathic Calcium Nephrolithiasis and Hypovitaminosis D: A Case-control Study.

Andrea Ticinesi1, Antonio Nouvenne2, Pietro Manuel Ferraro3, Giuseppina Folesani4, Fulvio Lauretani5, Franca Allegri2, Angela Guerra2, Nicoletta Cerundolo2, Rosalia Aloe6, Giuseppe Lippi6, Marcello Maggio7, Giovanni Gambaro3, Loris Borghi2, Tiziana Meschi2.   

Abstract

OBJECTIVE: To investigate the association between vitamin D deficiency (25-hydroxyvitamin D <20 ng/mL) and idiopathic calcium nephrolithiasis (ICN).
METHODS: A total of 884 patients with ICN (363 males, mean age of 51 ± 14) and 967 controls (162 males, mean age of 59 ± 15) from an area with no food fortification policy were considered following a case-control study design. Patients were enrolled at a third-level outpatient stone clinic. Controls were selected from a laboratory database after exclusion of those with nephrolithiasis, bone, endocrine, liver, and kidney diseases. Serum 25-hydroxyvitamin-D (25-OH-D), date of test, presence/history of diabetes, and cardiovascular disease including hypertension were recorded for all subjects. Serum parathormone, calcium, phosphorus, and urinary factors of lithogenic risk were available in stone formers (SF). After univariate statistical analysis, propensity score matching with conditional logistic regression was used to control for the possible effects of covariates.
RESULTS: The prevalence of 25-OH-D <20 ng/mL was 56% in SF and 44% in controls (P <.001), with median levels of 18 ng/mL [interquartile range (IQR) of 12-24)] versus 23 ng/mL (IQR of 14-30) (age and sex adjusted P <.001). After a fully adjusted conditional logistic regression analysis, performed on propensity-matched cohorts (442 SF, 442 controls), there was a statistically significant association between vitamin D deficiency and odds of nephrolithiasis (estimated odds ratio of 2.29, confidence interval 95% 1.74-3.02, P <.001). 25-OH-D levels were not different in hypercalciuric and normocalciuric SF (median and IQR of 18 ng/mL and 13-23 vs 19 ng/mL and 13-26, respectively, P = .2).
CONCLUSIONS: SF have lower serum 25-OH-D levels than controls. The role of hypovitaminosis D in the onset of ICN should be better reconsidered.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26494294     DOI: 10.1016/j.urology.2015.10.009

Source DB:  PubMed          Journal:  Urology        ISSN: 0090-4295            Impact factor:   2.649


  11 in total

Review 1.  Pathogenesis of calcium oxalate urinary stone disease: species comparison of humans, dogs, and cats.

Authors:  Allison L O'Kell; David C Grant; Saeed R Khan
Journal:  Urolithiasis       Date:  2017-03-30       Impact factor: 3.436

2.  Analysis of vitamin D deficiency in calcium stone-forming patients.

Authors:  María Sierra Girón-Prieto; María Del Carmen Cano-García; Miguel Ángel Arrabal-Polo; Antonio Poyatos-Andujar; Miguel Quesada-Charneco; Tomás de Haro-Muñoz; Salvador Arias-Santiago; Miguel Arrabal-Martín
Journal:  Int Urol Nephrol       Date:  2016-04-19       Impact factor: 2.370

3.  Vitamin D Intake and the Risk of Incident Kidney Stones.

Authors:  Pietro Manuel Ferraro; Eric N Taylor; Giovanni Gambaro; Gary C Curhan
Journal:  J Urol       Date:  2016-08-18       Impact factor: 7.450

4.  Effect of vitamin D supplementation on 24-hour urine calcium in patients with calcium Urolithiasis and vitamin D deficiency.

Authors:  Maryam Taheri; Sanaz Tavasoli; Fatemeh Shokrzadeh; Fahimeh Bagheri Amiri; Abbas Basiri
Journal:  Int Braz J Urol       Date:  2019 Mar-Apr       Impact factor: 1.541

5.  Association between vitamin D level and hematuria from a dipstick test in a large scale population based study: Korean National Health and nutrition examination survey.

Authors:  Hyunjin Ryu; Hyunjeong Cho; Yun Kyu Oh; Kwon Wook Joo; Yon Su Kim; Curie Ahn; Seung Seok Han
Journal:  BMC Nephrol       Date:  2019-05-24       Impact factor: 2.388

6.  Effect of Vitamin D Treatment on Dynamics of Stones Formation in the Urinary Tract and Bone Density in Children with Idiopathic Hypercalciuria.

Authors:  Joanna Milart; Aneta Lewicka; Katarzyna Jobs; Agata Wawrzyniak; Małgorzata Majder-Łopatka; Bolesław Kalicki
Journal:  Nutrients       Date:  2020-08-20       Impact factor: 5.717

7.  Obstructive urolithiasis in buffalo calves (Bubalus bubalis): Serum changes of Vitamins A and D and efficacy of surgical management using tube cystostomy.

Authors:  Abdelmonem Abdallah; Shimaa Ezzeldein; Eslam Eisa; Mustafa Abd El Raouf; Yasmin Bayoumi
Journal:  Vet World       Date:  2021-01-18

Review 8.  Medical therapy for nephrolithiasis: State of the art.

Authors:  Igor Sorokin; Margaret S Pearle
Journal:  Asian J Urol       Date:  2018-09-03

9.  Effect of Fat-Soluble Vitamins A, D, E and K on Vitamin Status and Metabolic Profile in Patients with Fat Malabsorption with and without Urolithiasis.

Authors:  Roswitha Siener; Ihsan Machaka; Birgit Alteheld; Norman Bitterlich; Christine Metzner
Journal:  Nutrients       Date:  2020-10-12       Impact factor: 5.717

Review 10.  Calcium and Vitamin D Supplementation and Their Association with Kidney Stone Disease: A Narrative Review.

Authors:  Matteo Bargagli; Pietro Manuel Ferraro; Matteo Vittori; Gianmarco Lombardi; Giovanni Gambaro; Bhaskar Somani
Journal:  Nutrients       Date:  2021-12-04       Impact factor: 5.717

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.